Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Double-Blind Phase	STARTED	AZLI-AZLI	134
Double-Blind Phase	STARTED	Placebo-AZLI	132
Double-Blind Phase	COMPLETED	AZLI-AZLI	96
Double-Blind Phase	COMPLETED	Placebo-AZLI	122
Double-Blind Phase	NOT COMPLETED	AZLI-AZLI	38
Double-Blind Phase	NOT COMPLETED	Placebo-AZLI	10
Open-Label Phase	STARTED	AZLI-AZLI	96
Open-Label Phase	STARTED	Placebo-AZLI	122
Open-Label Phase	COMPLETED	AZLI-AZLI	92
Open-Label Phase	COMPLETED	Placebo-AZLI	109
Open-Label Phase	NOT COMPLETED	AZLI-AZLI	4
Open-Label Phase	NOT COMPLETED	Placebo-AZLI	13

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01313624/flow